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A number of methods are currently employed to assess the functional properties of CFTR channels and their response to pharmacological
potentiators, correction of the defective CFTR trafficking, and vectorial introduction of new proteins. Here we review the most common methods
used to assess CFTR channel function. The suitability of each technique to various experimental conditions is discussed.
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Cystic fibrosis (CF) is caused by a genetic defect in the
Cystic Fibrosis Transmembrane conductance Regulator (CFTR)
protein, the only known member of the ATP-Binding Cassette
(ABC) family that behaves as an ion channel. In fact, when
CFTR pore opens, the flux of anions across the cell membrane
is driven only by their electrochemical potential [1]. As most
members of the ABC family, CFTR is composed of a
transmembrane domain (TMD), formed of 6 transmembrane
segments, followed by an intracellular nucleotide binding
domain (NBD). This motif is repeated twice, with the first
NBD linked to the second TMD by a regulatory domain (RD),
located in the intracellular compartment (see Fig. 1A), that
contains a considerable number of putative phosphorylation
sites [2].
CFTR is activated by protein kinase A (PKA), and probably
also by protein kinase-C (PKC) [3] phosphorylation at multiple
sites located at the RD. Because channel phosphorylation by
PKA is mandatory for channel activity, CFTR channel is also
defined as a “cAMP-activated channel”. Phosphorylated CFTR
channels are regulated by intracellular ATP. The most accepted⁎ Corresponding author. Tel.: +39 0106475558; fax: +39 0106475500.
E-mail address: moran@ge.ibf.cnr.it (O. Moran).
1569-1993/$ - see front matter © 2008 European Cystic Fibrosis Society. Publishe
doi:10.1016/j.jcf.2008.05.003model of CFTR gating proposes that binding of ATP promotes
the dimerisation of the NBDs, leading to a conformational
change at the level of the TM domains that in turn leads to
channel opening (Fig. 1B). The hydrolysis of ATP by the
enzymatic activity of the NBDs terminates the activity cycle,
releasing ADP (see Fig. 1C). Interestingly, this activity cycle is
not reversible (no ATP can be synthesised from ADP), but the
energy liberated by the hydrolysis of ATP is not used to
transport chloride. Indeed, once phosphorylated, ATP can be
opened by non-hydrolysable ATP analogues, such as 5′-
adenylyl-beta,gamma-imidodiphosphate (AMP-PNP) [4,5].
Immunological localisation of CFTR has revealed that it is
abundant in epithelial cells, including those lining the sweat
ducts, small pancreatic ducts, intestinal crypts, lung epithelia,
and the epithelia of kidney tubules, where the protein appears to
be restricted to the apical membrane. The cell and tissue
distributions of the CFTR chloride channel are consistent with a
function in vectorial ion movements across the epithelium.
Several reports have indicated that CFTR is also expressed in
the heart and in the central nervous system, but its functional
relevance has not yet been elucidated.
Although the exact mechanisms leading to CF pathology is
still a question of debate, the disease is associated to a strong
reduction/absence of chloride ion transport across the apical
membrane of the epithelium. There is a clear correlationd by Elsevier B.V. All rights reserved.
Fig. 1. A: Topology of the CFTR inserted in the cell membrane. The two
transmembrane domains, TM1 and TM2, are composed by 6 membrane
spanning helices each; the two nucleotide binding domains, NBD1 and NBD2,
are located in the c-terminus of each TMD, in the cytoplasm, the regulatory
domain, RD, joins NBD1 to TMD2. B: The functional cycle of CFTR. Protein
kinase A (PKA) is activated by the cytoplasmic cAMP, and catalyses the
phosphorylation of the RD of inactive CFTR, promoting a conformational
transition that leads to active CFTR. The binding of ATP to the NBDs induces a
second conformational change, that gates the channel to the open – chloride
permeable – conformation. C: The gating cycle of the NBDs of CFTR initiates
with the successive binding of two ATP molecules, that induces the dimerisation
of these domains, by a quasi-irreversible transition, allowing the channel to
open. The ATPase activity of the NBDs brings on the hydrolysis of one ATP, and
the consequent destabilisation of the NBD1–NBD2 interaction, that causes the
closure of the channel and the release of an ADP.
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of CF phenotype: the most severe loss of function mutations in
CFTR are associated with the most severe forms of CF. The
measurement of CFTR ability to transport chloride is
considered a good, and perhaps, the only practical method to
assess its activity. Hence, it is used to analyse CFTR mutants
and to evaluate the effects of procedures intended to remediate
the abnormal protein, such as pharmacological potentiation of
defective CFTR, correction of the defective CFTR trafficking,
and vectorial introduction of new proteins, or development of
any other therapeutic strategy.Physiologists and biophysicists have developed a number of
different methods to quantify the transport across membranes,
based on 1) the measurement of ionic currents, 2) direct
evaluation of the fluxes, using chemical methods like radio-
isotope tracers or fluorescent probes, and 3) indirectly, by cell
membrane potential measurements. Each of these strategies has
a broad number of variants that vary in their intrinsic accuracy.
Therefore, the choice of the method has to be decided taking
into account the biological preparation used (purified protein,
isolated cells, tissue samples or whole organisms), the
complexity level that it is under examination (single-channel
properties, cellular responses or tissue responses), the measur-
able parameter (expression, level of activity, pharmacological
responses), and the throughput of the experiment (large
screening vs. detailed characterisation).
Frequently, scientists involved in CF research have to face
the necessity to evaluate their results in terms of the functional
properties of CFTR. To aid researchers in choosing the
technique that best suits their needs, we have compiled a list
of techniques to measure CFTR channel activity, including
some comments on the systems on which they can be applied.
This article does not intend to be an exhaustive description of
each method, that can be better obtained from the specific
references, but seeks to provide a panoramic view of the
techniques as an initial resource to design an experimental
strategy.
2. Activation of CFTR
As mentioned above, CFTR attains the activated state when
the RD is phosphorylated by PKA (see Fig. 1B). In patch-clamp
experiments and reconstituted CFTR experiments, where it is
possible to perfuse the intracellular side of the membrane,
phosphorylation (and the subsequent CFTR activation) can be
obtained by applying the catalytic subunit of PKA.
Differently, CFTR activation in intact cells requires stimula-
tion of the endogenous PKA by increasing the cytoplasmic
concentration of cAMP. This can be obtained in an indirect
mode, stimulating the cell production of cAMP via activation of
adenylate cyclase by a G-protein linked hormone pathway,
using glucagon, epinephrine or a beta-adrenergic agonist like
isoproterenol, acetylcholine, the vasoactive intestine peptide
(VIP) [5a] or adenosine [5b]. The level of intracellular cAMP
obtained by hormonal stimulation and, thus, the maximal
activity of CFTR, might be well below the levels obtained by
using forskolin or permeant cAMP analogues.
In the laboratory, activation of adenylate cyclase is usually
obtained by application of forskolin, a terpene derivative of
plant origin. Extracellular application of micromolar concentra-
tions of forskolin (0.5–10 μM) leads to an intracellular increase
of cAMP sufficient to activate the PKA, with the consequent
activation of the CFTR. However, high concentrations of
forskolin (N20 μM) may produce unspecific responses,
probably via interaction with metabolic pathways. The increase
of cAMP after forskolin probably triggers a feedback mechan-
ism, since addition of this compound to an epithelium elicits a
CFTR activity characterised by an initial fast increase followed
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maintained as long as forskolin is present. The activity
reduction could be a consequence of cAMP-concentration
reduction following activation of phosphodiesterases (PDE).
Therefore, to activate CFTR it is sometimes used a cocktail
containing forskolin and a PDE inhibitor like IBMX [7].
However, care has to be taken when using IBMX, since it seems
to have a direct action on the gating properties of CFTR [8–10],
being a potential source of interference in the measurements,
especially when studying the modulation or the pharmacology
of CFTR.
The activation of PKA can be also obtained by the direct
application of membrane permeable analogues of cAMP, like
CPT-cAMP or 8-Br-cAMP. Response to exogenous cAMP
seems less disturbed by feedback mechanisms. Extracellular
application of micromolar concentrations of CPT-cAMP leads to
a consequent activation of CFTR in a quite reproducible dose–
response manner (K0.5 ~80 μM). Phosphorylation of CFTR by
PKA is a reversible reaction, as the RD is dephosphorylated by
serine/threonine-specific protein phosphatases. It is thus com-
pulsory to maintain agonists that activate PKA – or the catalytic
subunit of the PKA in patch experiments – during CFTR
recordings in order to sustain channel activation. Alternatively, itFig. 2. Schematic representation of the most important epithelial Na+ and Cl− transp
ENaC channel and leaves the cell mainly through the Na/K-ATPase. Cl− instead ente
the cell at the apical side either through CFTR or through a Ca2+-dependent channel (C
and a cAMP-dependent system (in green). An increase of the intracellular Ca2+ conc
receptors, such as P2Y receptor activated by UTP or ATP, or themuscarinic acetylcho
be a consequence of the binding of agonists on apical or basolateral receptors, suc
intestinal peptide receptors (VIP). Also bicarbonate, formed from CO2 by carbonic an
way with Cl− channels provides the driving force needed for Cl− secretion. Grey bois possible to inhibit the phosphatases [6], increasing the effect of
the PKA agonists.
Sometimes, cells or tissues in resting conditions may have
intracellular levels of cAMP that are high enough to activate
PKA and maintain a basal CFTR activity. It is important to take
into account this possibility when studying the modulation of
CFTR gating or its pharmacology, since phosphorylation can
condition the channel responses [11,12]. It is, therefore,
necessary to design experiments with appropriate controls of
the basal condition of CFTR using specific blockers, such as
CFTRinh-172. It is important to be aware that the use of non-
specific blockers, like the sulfonylurea glibenclamide may
introduce further artefacts to the measurements due to its action
on other transport systems, such as ATP-sensitive potassium
channels [13].
The discovery that deletion of RD results in permanently
activated CFTR channels has allowed to bypass the phosphor-
ylation-dependent activation providing a useful tool for
biophysical and pharmacological studies of CFTR. This deletion
results in channels that are active in basal conditions but
maintain most of wild-type gating properties [14,15]. However,
the deletion of the RD seems not to be sufficient to completely
activate CFTR channels, and further phosphorylation isort systems. Na+ enters the cell from the apical side of the epithelium through
rs the cell from the basolateral side through the NPCC-co-transporter and leaves
aCl). Thus, Cl− secretion has been divided into a Ca2+-activated system (in red)
entration can be triggered by agonists acting on apical or basolateral membrane
line receptor activated by acetylcholine (ACh). Similarly, a cAMP increase might
h as adenosine, beta beta-adrenergic (Epi), prostaglandin PGE2, or vasoactive
hydrase, permeates CFTR. Activation of basolateral K+ channels in a concerted
xes indicate some channels or transporter inhibitors.
486 O. Moran, O. Zegarra-Moran / Journal of Cystic Fibrosis 7 (2008) 483–494necessary to obtain full activation. Introduction of other
mutations on putative phosphorylation sites along the NBD1
may also improve the CFTR activation.
In phosphorylated channels and in the presence of ATP the
two NBDs can dimerise and together form two binding sites for
ATP [16,17]. This promotes the open state of the channel (see
Fig. 1C). While the first site seems to be a stable binding site at
which hydrolysis does not take place, or occurs at a very slow
rate, at the second site ATP is promptly hydrolysed [4]. Binding
of ATP at the two sites might be the power stroke that opens the
channel, and the energy of hydrolysis at the second site
terminates the transport cycle (Fig. 2) [16,17]. When working in
conditions where the intracellular solution could be set up by
the researcher (e.g. whole cell or inside-out patch-clamp
configurations) it is important to work with high concentrations
of intracellular MgATP (about 0.3–1 mM) to ensure that
binding and hydrolysis of ATP can occur and the activity cycle
of CFTR can be completed.
3. Experimental systems: cells and tissues
Experimental systems to study CFTR function span from
purified protein molecules, to single cell, to artificial or native
tissues (Table 1). Each system provides advantages and
disadvantages. In general, the resolution and the precision of
the measurements are inversely proportional to the complexity
of the biological system.
3.1. Reconstituted CFTR
Purified CFTR channels can be obtained from preparations
of recombinant proteins or from cell fractions and then
reconstituted into planar lipid bilayers or in liposomes. TheTable 1
Experimental systems for the study of CFTR chloride transport function
System Comments on its application
Reconstituted systems
Incorporation into lipid bilayers Limited to detailed biophysical and p
can be used for patch-clamp recordiProteoliposomes
Isolated cells
Primary cultures Detailed biophysical and pharmaco
cellular response information. Exce
membrane traffic and sorting
Cell lines expressing CFTR
Transiently or permanently transfected cells
cRNA expression in oocytes Limited to biophysical and pharma
Cell monolayers
Made by primary cultures, cell lines expressing
CFTR or permanently transfected cells
Good for biophysical and pharmaco
absorption. Serious difficulties for h
long-lasting experiments. Problema
Biopsic samples
Ex vivo dissociated cells Good for pharmacology and for se
secretion or absorption. Excellent
lasting experiments after obtaining
Integral epithelial samples
In situ
Nasal or rectal epithelia Semi-quantitative method. Excellecomplexity of the CFTR folding limits the production of
recombinant proteins to eukaryotic systems like insect cells
infected by baculovirus [18] or mammalian cells [19,20].
Simpler methods, like production of proteins in bacteria are
limited by the impossibility to obtain an adequate folding.
Affinity chromatography-purified recombinant CFTR has been
successfully used to study single-channel properties when
incorporated in planar membranes [18,19]. Preparations of
microsomal membrane fractions have been used extensively to
reconstitute CFTR activity [21,22]. Microsomal membranes can
be easily prepared from cells expressing wild type or mutant
CFTR, allowing to measure the chloride transport in either
planar lipid membranes or proteoliposomes, and to study the
biochemistry of enriched fractions of CFTR in proteoliposomes
[23].
3.2. Cells expressing CFTR
Isolated cells are the preferred system to study CFTR
activity. A large number of different techniques can be applied
to measure chloride transport in these preparations. Isolated
cells can be obtained as primary or secondary cultures from
specimens obtained from patients or animals, and grown
following appropriate culture techniques. These cells have the
advantage that they preserve quasi-native conditions, suitable
for physiological studies. However, some care has to be taken
since these cells could undergo an atypical differentiation in
culture that modify their characteristics.
There is a considerable number of commercially available
cell lines expressing CFTR. For example the Human Genetic
Cell Repository of the National Institute of General Medical
Sciences of USA, with more than 200 entries can be an
interesting source of specific cell lines carrying CF mutations.harmacological characterisation ofCFTRby currentmeasurements. Proteoliposomes
ng, flux measurements by radiotracers and fluorescent probes assays
logical characterisation of CFTR. Ideal for screening of expression. Can provide
llent for high throughput screening design. Potential risks of incorrect
cological characterisation by two electrode voltage-clamp or patch-clamp
logical characterisation of CFTR or for transepithelial transport— secretion or
eterologous expression when the cell monolayer is formed. Can be used for
tic to design high throughput experiments
mi-quantitative expression tests. Adequate for transepithelial transport —
to control chronic treatments on animals or patients, but difficulties for long-
the sample. Not suitable for high throughput experiments.
nt to control acute or chronic treatments on animals or patients
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487O. Moran, O. Zegarra-Moran / Journal of Cystic Fibrosis 7 (2008) 483–494Several academic institutions conserve and distribute cell lines
generated from cystic fibrosis patients, like the Laboratory of D.
C. Gruenert at the University of California in San Francisco
(USA), that has a collection of immortalized bronchial
epithelium cells with CFTR mutations [24].
Heterologous expression of wild type or mutant CFTR in
cell lines (e.g. HEK, CHO, etc.) is also widely used.
Transient expression leads to sufficient channel expression
for techniques intended for measurements on single cells, like
patch-clamp or imaging studies. However, transient transfec-
tion is associated to large cell to cell variability in the level of
CFTR expression that may constitute a problem when
performing experiments based on the measurement of a
population of cells (e.g. fluorescence assays, anion fluxes,
etc.). Moreover, transient transfection of the exogenous
cDNA is maintained for a short time (typically 2–3 days).
These problems are resolved with permanent transfections of
CFTR cDNA. This method results in a clonal selection of
transfected cells providing a good homogeneity of expres-
sion. In conclusion, in contraposition to the fast and simple
protocol of transient transfected cells, the time consuming
protocol to obtain permanent transfection has the major
advantage of better quality of the results for most of the
functional measurements of CFTR.
3.3. Polarised cell monolayers and epithelia
Cell monolayers constitute an excellent model of the
epithelium. When cells grow in the appropriate conditions to
form a polarised monolayer, the plasma membrane transport
proteins distribute differentially between the apical membrane
and the basolateral membrane. A strong, obvious, limitation of
this system is the restriction to epithelial cells that are able to
differentiate into polarised cells and form tight junctions. As the
cell interstices are “sealed” by tight junctions, most of the solute
transport occurs across the cell, crossing both, the apical and
basolateral membranes, with mechanisms similar to those of an
epithelium (see below). Therefore, to obtain reliable measure-
ments of CFTR-mediated chloride transport across the cell
monolayer, it is necessary to verify the “closure” of the
interstices before attempting any measurement otherwise there
is the risk of measuring leak of solutes by the paracellular
pathway. This technique can be applied to some epithelial cell
lines, permanently transfected cells, or primary epithelial cells.
However, it is unlikely to get acceptable results using transient
transfected cells, as the long time necessary to form a good
enough monolayer is too long (usually between 4 and 7 days)
compared to the short time with acceptable CFTR expression in
isolated cells (usually less than 72 h).
An interesting variant of this technique is the electrical
exclusion of the basolateral membrane by its permeabilisation
by channel-forming antibiotics or bacterial toxins (see below).
In this configuration it is possible to simplify the system for
measuring CFTR permeation, as this protein is expressed
almost exclusively in the remaining apical membrane.
Another important point that needs to be taken into
consideration is that cell lines of epithelial linage do not
488 O. Moran, O. Zegarra-Moran / Journal of Cystic Fibrosis 7 (2008) 483–494reproduce exactly the properties of native epithelial cell. Most
of these lines are polyploids, and immortalisation surely
changes the panel of expressed proteins. In fact, some of them
completely lose the possibility to polarise (A549, 9HTE), others
lose the apical expression of the epithelial sodium channel
ENaC (CFBE14o-, 16HBE41), or may present significant
differences on the protein traffic and sorting; moreover other
less evident changes, such as the intracellular control of the
concentration of cAMP, could have taken place. As a
consequence, while any cell could be a good support to study
isolated CFTR protein or the effect of compounds acting
directly on the protein, studies on the regulation of CFTR or on
compounds that might modify the activity of CFTR by
interacting at different levels with the cell machinery, may
need to be carefully evaluated. In these last cases, it could be
useful to verify the effect measured on a certain cell line on
other cells or, even better, on primary cultures. Different results
could be also obtained measuring the effect of a given
compound on CFTR from different species. Recent data [25]
have evidenced for example that mice carrying the dF508
mutation have more protein in the plasma membrane. Thus,
evaluation of potentiators of CFTR could be better studied there
than on human cells, where the mutated protein is almost absent
from the membrane, while the effect of correctors would be
scarcely evaluated is this preparation.
3.4. Ex vivo and in situ preparations
Cell preparations from biopsic material are among the more
physiological preparation, being an excellent choice to study the
result of a given procedure on the whole organism. However, in
contrast to in vitro preparations which are treated (immorta-
lized) to be maintained for a long time in laboratory conditions,
biopsic material in the form of isolated cells or tissue samples,
could be significantly damaged during the isolation procedure.
These systems have also limited time viability, before
developing an adaptation to the new in vitro situation, moving
away from the physiological conditions that justify its use, or
dying. These characteristics limit the manoeuvrability of these
preparations, and in some instances, require a more constringent
control to asses the quality of data obtained. For example, some
transport mechanisms are expressed only when the cell is
polarised. A classical example is the epithelial sodium channel
(ENaC), that is well expressed in the apical membrane, and is
directly involved in the regulation of the apical membrane
permeability in epithelia. Endogenous expression of ENaC is
completely inhibited when cells are dissociated, and the rapid
turnover of this channel leads to reduction of the sodium
transport throught ENaC within few hours.
Similarly, in situ studies are strongly limited by the need
of using non-invasive procedures to conserve the physiolo-
gical attributes of the measurement, and to protect the subject
in the case of measurements done in humans. It is, however,
an essential method to be used to ascertain if a given mech-
anism described in vitro, or a given procedure developed in
isolated systems can be adequately extended in the whole
organism.4. Methods of measurement
Methods to evaluate CFTR activity can be divided into two
groups: a) electrophysiological methods, based on the measure-
ment of i) the ionic currents or ii) the membrane potential, and
b) methods to determine ion fluxes, either directly via
radioisotopes or chemical methods, or via techniques that
apply fluorescent probes.
4.1. Ionic current measurement
The measurement of ion currents is a method for the direct
evaluation of the net ion flux across a semi-permeable barrier
like a membrane (or an epithelium). The flux J (mol/s) across
the barrier is described by the Fick's law as:
J ¼ PDc
where P (s−1) is the permeability coefficient, and Δc is the
concentration gradient (mol/l/m). For a flux of charged ions, we
can convert J in electric current, I, expressed in Amperes
(Coulomb/s), by multiplying the flux by the Faraday constant
(F=96,000 Coulomb/mol). Likewise, the concentration gradi-
ent can be converted in electrochemical potential Vi for the ion
i, by the Nernst's law:
V1 ¼ RTzF ln
c1
c2
 
where R is the universal gas constant (8.314 V Coulomb K−1
mol−1), T is the absolute temperature (K), z the valence of the ion,
and c1 and c2 are the concentrations at either side of the barrier.
The measurement of ionic currents can be obtained via
voltage-clamp. A voltage-clamp amplifier is a device that allows
to maintain a fixed command potential, Vcom, between the two
sides of the barrier, while the circuit measures the current
necessary to maintain this potential, that is equal (and opposite) to
the current that flows across the membrane. Hence, for a system
with an electrochemical potential Vi, at a given command
potential Vcom, the current is described by the Ohm's law as:
I ¼ G Ccom  Við Þ
where the conductance, G (Siemens), is the inverse of the
resistance. There are several different types of voltage-clamp
methods, suitable for different preparations, from small patches of
membranes to whole cells, very big cells, or to measure currents
across complete epithelia. An important characteristic of all
voltage-clamp techniques is their considerable time resolution,
providing information on the kinetic properties of the CFTR
channels and on the precise time course of a modulatory or
pharmacological intervention. A briefing on the most common
voltage-clamp methods applied to CFTR functional measure-
ments are described in Table 2.
4.1.1. Patch-clamp
The patch-clamp technique is an electrophysiological
technique originally designed to measure single-channel events
[26], and successfully extended to the measure of whole cell
Table 3
Methods to measure the membrane potential in cells and tissues
Method Isolated
cells
Monolayers Biopsic
preparation
In situ Comments
Cell membrane
potential
Fair Fair Fair Difficult Requires expertise. Not suitable for screening
Potential sensitive
fluorescent dyes
Good Good, but
difficult to
interpret
Good Difficulties loading the probe to cells and
accessing the tissue with optical instrumentation
Good qualitative method. Good for
high throughput screening.
Transepithelial
potential
Not
applicable
Good Fair Most suitable method for non-invasive
measurements in live animals and human patients
Good technique for in situ. In isolated epithelia,
it is a good choice for inexperienced operators
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electrical isolation of a small patch of membrane by means of
the tip of a glass micropipette. According to the size of the
isolated patch of membrane and on the density of CFTR
expression in the membrane, a single channel or multiple
channels can be recorded. The patch-clamp technique has been
successfully applied to almost any type of dissociated cell, as far
as their surface is accessible and clean. Cell lines usually are
easier to patch than primary cultures and freshly dissociated
cells. Several details on the patch-clamp preparation condition
the success of patching, like the temperature, presence of
divalent cations, and presence of proteins or nucleotide in the
pipette. Unfortunately, there is no fixed recipe to obtain
successful patches, but ideal conditions have to be found for
each preparation.
Several different variants of the original technique were
obtained. In the cell-attached configuration the integrity of the
cell is maintained and currents are measured upon stimulation
by membrane permeable agonists (see above). However, this
configuration has the disadvantage to have no access to the
intracellular side of the channel, and a very difficult access to
the extracellular side. In addition, the cell resting potential is
unknown. There are two excised patch configurations, the
inside-out and the outside-out configuration. The inside-out
configuration is probably mostly used to record single CFTR
channels. With this configuration, the intracellular side of CFTR
is exposed to the bath solution, and therefore can be easily
perfused with various solutions containing kinases, nucleotides
and other substances. In this configuration, it is possible to
induce the phosphorylation of CFTR by direct application of
PKA catalytic fraction, and to keep it in the solution all along
the experiment to keep CFTR in the activated state.
The whole cell configuration is also extensively used to
record CFTR chloride currents, in particular to study pharma-
cology and channel biophysical properties. In this case, because
the cell is dialysed by the pipette solution, it is necessary to
supply the cell with PKA and ATP directly in the pipette
solution. A variant of the whole cell configuration is the
perforated patch. In this configuration, the patch of membrane
under the pipette is “perforated” by channel-forming antibiotics
(as nystatin, gramicidin) or bacterial toxins (alpha-toxin),
gaining electrical access to the cytoplasmic side, but avoiding
the lost of intracellular macromolecules, keeping most of the
cell machinery. This is a very good method to study themodulation of channels that strongly depends on the intracel-
lular milieu.
The patch-clamp technique is among the highest resolution
methods to study ionic currents. In the appropriate conditions, it
is possible to resolve single-channel events as small as 0.1 pA,
with a bandwidth of 5 kHz. It is indeed the best choice to study
the molecular mechanisms of the gating of CFTR and its
modulation. The traditional, hand-operated method is not
appropriate for screening experiments, because it requires
some expertise and manual ability, and the acquisition of data
could be extremely time consuming, resulting in a low-
throughput system. A good alternative for screening is the use
of automated patch-clamp systems that have been recently
introduced in the market [30–32].
4.1.2. Two electrode voltage-clamp
Two electrode voltage-clamp is a good method to record
CFTR currents expressed in frog oocytes [33]. This technique is
relatively easy and can be appropriate for the screening of
substances in a moderate throughput. However, when using two
electrode voltage-clamp, one has to be conscious about the
resolution limitations due to the big size of the oocytes (about
1 mm diameter), that generates problems with correct control of
the potential, especially when relatively high currents are
recorded [34]. This problem can be avoided applying the patch-
clamp techniques to oocytes, improving the time resolution, but
reducing the throughput of data.
4.1.3. Ussing chamber
The Ussing chamber, originally introduced by Prof. Hans
Ussing to study the ionic transport across the frog skin [35], can
be applied to study ion transport through various types of
epithelia and cell monolayers. The method consists of the
measurement of current (or voltage) between two hemi-
chambers separated by a section of an epithelium or an
epithelial cell monolayer grown on a permeable support. Fig. 2
shows a scheme of an epithelium (or cell monolayer).
The distribution of channels and transporters may vary
considerably between epithelia of different organs, but most
surface epithelia, including the airways epithelia, are basically
sodium absorptive. In fact, the proximal airways have the
important role of removing water produced deeply in the large
surface of small bronchi branches and alveoli. In absorptive
epithelia sodium enters the cell from the apical side through the
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side through the Na/K-ATPase. Sodium movement is accom-
panied by chloride, passing probably through the paracellular
pathway, and osmotic water. Given the intracellular and
extracellular concentrations of chloride, there is no driving
force for chloride movement in resting conditions. However, it
is believed that, under hormonal stimulation, activation of
basolateral potassium channels causes cell hyperpolarisation
providing the driving force that permits chloride secretion.
Chloride enters the cell basolaterally through the sodium,
potassium and chloride co-transporter (NKCC), and leaves the
cell at the apical side through chloride channels such as CFTR.
The electrical equivalent circuit of an epithelium (see Fig. 2)
consists of two resistors, RA and RB, representing the apical
membrane and the basolateral membrane respectively, in series
with two batteries that yield the potential difference of these two
membranes, VA and VB. The transepithelial potential difference
is defined as VT= VB−VA. In parallel there is another resistance,
Rp, called also “leak resistance”, representing the cell interstice
where ions could permeate, named the paracellular pathway.
The total resistance of the epithelia, RT, is therefore described
by:
RT ¼ Rp RA þ RBð ÞRp þ RA þ RB :
Leakiness of the tight junction between cells, that determine
Rp, represents an important contribution to RT. To measure the
current flowing through the channels, that is the transcellular
current, it is necessary to have a reduced flux by the paracellular
pathway, i.e. to have high Rp values. Hence, to obtain good
measurements of the currents across channels, it is necessary to
have epithelia with relatively high RT values. According to the
value of the transepithelial resistance, epithelia have been
arbitrarily classified as “tight”, with RT ≥1.5 KΩ cm−2, and
“leaky”, for RT b1.5 KΩ cm
−2. Leaky epithelia have higher
water and sodium permeability than tight epithelia, but cannot
maintain or create a gradient. Leaky epithelia have VT b10 mV,
while higher VT values, up to several tens of mV can be
observed in tight epithelia.
The classical parameter measured in an epithelium mounted
in an Ussing chamber is the “short-circuit current”, ISC, that is
the current across the epithelium when is short circuited, i.e. VT
is clamped to 0 mV. As mentioned before, in most in vivo
epithelia and in epithelia that keep some of their physiological
features, sodium contributes to a significant extent to ISC, and
therefore, to evaluate the chloride current flowing through
CFTR channels it is necessary to inhibit this cation current. The
transcellular sodium current can be completely eliminated by
the addition of micromolar concentrations of the ENaC blocker
amiloride to the apical side of the epithelium. Attention has to
be paid to the dosage of amiloride as at high concentrations it
could modify also other mechanisms that might be present in
some epithelia. Assuming that the paracellular current is small
enough, after application of amiloride, the transepithelial
current approximates zero. In this condition, it is possible to
activate chloride fluxes through the different chloride channelspresent in the epithelial, including CFTR. As mentioned before,
addition of forskolin or permeable cAMP analogues activates
CFTR. However, to obtain another indication that the current
measured is indeed conducted by CFTR, it is desirable to use
specific blockers at concentrations as low as possible. On most
human cells, CFTRinh-172 blocks CFTR completely at
concentrations between 5 and 10 μM. In addition, appropriate
controls to estimate the paracellular contribution to the total
current are necessary to obtain reliable data.
Several variations of the classic Ussing chamber have been
applied to a large number of different epithelial preparations to
measure CFTR activity, from monolayers formed by cells
grown on permeable supports developed to be inserted in a
chamber [12,36], to biopsic samples [37–40]. An interesting
variation of the method is obtained by permeabilising the
basolateral membrane with an antibiotic, like nystatin or
amphothericin [41], or by Staphylococcus aureus alpha-toxin
[42]. These agents form pores in the membrane, that becomes a
low resistance pathway for ions across the basolateral
membrane virtually suppressing RB. It results in a configuration
where (assuming a high paracellular resistance) most of the
current flows across the apical membrane, improving consider-
ably the specificity of the measurement of CFTR channels. Note
that channels formed by antibiotics or alpha-toxin are perme-
able to ions, but not to macromolecules, or even low molecular
weight substances, like nucleotides, leaving the intracellular
composition, except for ions, quite constant.
4.2. Membrane potential measurements
The cell membrane potential is firmly coupled to the
membrane permeability and the ionic gradient across the
membrane. The resting cell potential, Vr, can be estimated
from the Goldman–Hodgkin–Katz equation as:
Vr ¼ RTF ln
PK K½ i þ PNa Na½ i þ PCl Cl½ O
PK K½ O þ PNa Na½ O þ PCl Cl½ i
 
where Pj is the permeability of membrane for the ion j, and i and
o represent the intracellular and extracellular concentrations of
each ion, respectively. A modification of the membrane
permeability for any ion, for example as a result of activation
or inhibition of a channel, will result in a modification of the
membrane potential. However, quantification of such modifica-
tions in terms of change of the conductance of a channel is not
immediate. Modification of the membrane potential will
influence other channels, in particular several types of inward
rectifier and voltage dependent potassium channels and chloride
channels of the CLC family, which, in turn, will modify the
membrane potential. When the channel under investigation is
over-expressed in the cell, accumulation or depletion of the
permeant ion will create a further inconvenience, as the ion
electrochemical gradient will influence the potential. In conclu-
sion, while membrane potential measurements can be useful for
a simple control of a modification of CFTR (or any other)
channel function, quantitative analysis of such modifications
will be difficult. It is important to notice that in physiological
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chloride concentration, the chloride equilibrium potential is very
near to the membrane potential. Thus, modifying the chloride
activity, either activating or inhibiting CFTR, does not produce a
significant change in the membrane potential. Therefore, to
detect the CFTR activity bymeasuring the membrane potential it
is necessary to reduce the extracellular chloride to obtain an
electrochemical gradient that produces a voltage change when
the chloride permeability is modified.
Direct methods for measuring the membrane potential are the
use of intracellular microelectrodes and the whole cell patch-clamp
recording, in the current-clamp configuration (Table 3). In fact,
these are the appropriate techniques to control the validity of other
methods, like those that use fluorescent voltage sensitive dyes [43].
Intracellular microelectrodes have several advantages over the
patch-clamp. Patch-clamp requires the direct access of the pipette to
the membrane, that in intact epithelia is often possible only after
enzymatic treatments that may change the state of the tissue. On the
other hand, the fine tip of the electrode prevents damage and
preserves the physiological micro-environment of the cell, while
the patch-clamp electrode dialyses the cell cytoplasm. These two
techniques can be used for almost any preparation, within the limits
of accessibility of cells and membranes, but require expertise and
manual ability. Complexity of the method (mechanical stability,
electrical screening, micro-manipulation of the electrodes under
microscope observation) makes it difficult to apply on in situ
preparations, or to use in high throughput experiments.
An alternative approach to measure the membrane potential
is to use fluorescent dyes [44]. The bisoxonol compound
DiSBAC2(3) has been used to assess the expression of CFTR
[45]. A precise calibration of the fluorescent signal against the
absolute cell membrane potential is hardly possible, but the
DiSBAC2(3) signal is very well correlated with the potential
changes [43]. This compound presents several advantages
including a rapid and simple handling, the possibility to apply
the method to a large number of airway cells, for example cells
obtained from nasal or bronchial brushes, and it is suitable for
high throughput screening experiments. However, the time course
of DiSBAC2(3) fluorescence response to a change of membrane
potential has a time constant of hundreds of seconds [45,43], thus
precluding the implementation of kinetic experiments. Kinetic
properties of the membrane potential changes are better assessed
with electrophysiological methods, that have time responses
between tens of microsecond to few milliseconds.
As mentioned above, when polarised cells adhere to each other
by tight junctions, forming an epithelium, a transepithelial
potential, VT, is mainly a result of the contribution of the sodium
and chloride transport systems (see Fig. 2). Thus, measurements of
changes of transepithelial potential VT in response to channels
activators or blockers, or changing the permeant ions concentra-
tion, could reveal the contribution of different channels to the
transepithelial potential. This technique is particularly suitable for
studies onwhole animals and can also be applied to human patients
[46–50]. Transepithelial nasal or rectal potential can be measured
introducing an electrode in the liquid layer adjacent to the apical
side of the epithelia (the nose or the rectal cavities), and measuring
the potential difference against a hypodermic reference electrode.Several commercial devices have been designed to normalise the
measurements, and to allow perfusion of the epithelia with
solutions of different composition. The sequential additions of
amiloride to block ENaC currents, low chloride solution to
increase the driving force for chloride secretion, cAMP to activate
CFTR, and a CFTR inhibitor, provide a good insight in the level of
CFTR activity. The method has been proved to be appropriate for
diagnosis or to evaluate the result of clinical tests [51,52].
Transepithelial potential is also a good parameter to evaluate
the quality of polarised cell monolayers in culture, as many tight
monolayers develop a transepithelial potential. We consider that
thismethod could be used as a simple technique to evaluate CFTR
activity. Potential difference can be simplymeasured between two
Ag||AgCl electrodes, using a voltmeter. Electrodes can be made
with a silver wire that has been immersed for a couple of minutes
into bleaching. To avoid electrode unbalance when using low
chloride solutions, and to assure the sterility of cells, the
electrodes are connected to the chamber solutions through
single-use Ringer-agar bridges. Modern digital multimeters are
ideal for these measurements, as they have adequate impedance,
and can be also used to measure the transepithelial resistance by
switching the instrument to the ohmmeter mode. The easy access
to the monolayer solutions allows the application of modulators
and drugs similar to those described above. A further advantage is
that, if experiments are done with adequate precautions to avoid
contamination, measurements can be repeated in time, allowing
the design of chronic experiments. This is probably the easiest and
cheapest method to evaluate CFTR function.
4.3. Chloride fluxes assays
Chloride fluxes can be determined by evaluating the mass of
ions incorporated into stimulated cells, or the release of ions from
the stimulated cells. The use of radioactive tracers is probably one
of the most precise methods to determine the ionic flux. It has the
advantage that even in the absence of a net flux of chloride, when
the electrochemical potential is zero, it is possible to determine the
activity of CFTR from the unidirectional radiotracer movement.
The method is quite well applicable to most preparations, except
the in situ systems, due to the difficulty in using radioactive
material on living animals or human patients (Table 4).
An equivalent method is based onmeasurements of iodide flux.
Because the CFTR channel is permeable to iodide, it is possible to
determine the efflux of this ion from previously loaded cells by a
colorimetric assay [53] or using an iodide-selective electrode [54–
56]. All these flux measurements have the inconvenience that, in
most cases, efflux determination is more reliable than influx
measurement, but implies that cells have to be preloaded with the
radioactive marker or iodide, by relatively long incubation.
Fluorescent probes can be used to estimate the intracellular
chloride (or iodide) concentration changes, with a reasonable
time resolution. There are several different fluorescent probes
to apply for halide determination, as MQAE (N-(ethoxycarbo-
nylmethyl)-6-methoxyquinolinium bromide) [57,58], SPQ (6-
methoxy-N-(3-sulfopropyl) quinolinium) [59,60,57], MEQ (6-
methoxy-N-ethyl-1,2-dihydroquinoline) [61,62]. All these dyes
have to be loaded into cells before performing the experiment.
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492 O. Moran, O. Zegarra-Moran / Journal of Cystic Fibrosis 7 (2008) 483–494Alternatively, it is possible to transfect cells with green
fluorescent protein variants, like some YFP mutants, whose
fluorescence can be differentially quenched by various halides
[63–65]. While GFP-CFTR transgenes have been successfully
used to express different CFTR proteins and track their trafficking
towards the plasma membrane [66–68], the link of GFP or other
flags to CFTR might disrupt the interactions with PDZ motifs
(flags located near the C-term of CFTR), the regulation by
syntaxins (flags linked near the N-term), or with other regulatory
factors. Therefore, care must be taken with generalisation of
results regarding the regulation of the protein when these results
are obtained using tagged-CFTR, since the experimental settings
might not reflect physiological conditions. Conversely, co-
expression of CFTR with other fluorescent proteins, as halide-
sensitive YFP seems to not affect the CFTR physiology.
Different measurement modalities can be applied to detect
chloride transport activity. Upon activation of CFTR channels,
changes in the intracellular chloride can be detected directly with
a chloride-dependent fluorescent dye, or indirectly as the dye
fluorescence quenched by other permeable anions, like iodide or
bromide. When measuring fluxes using chloride-dependent
fluorescent probes, a chloride gradient must be imposed.
Fluorescent responses can hardly be calibrated to obtain absolute
flux values, but changes in fluorescence should be related to the
chloride channel activity. The flux is usually estimated in terms of
the maximum derivative of the fluorescence signal [65]. When
using fluorescent probes, it is important to take into account the
possibility of signal interferences by intracellular changes on pH,
interferences caused by pharmacological substances assayed, or
the autofluorescence of some of such substances, that can alter the
response of some fluorescent dyes.
Fluorescent dyes have the advantage that they can be applied
to almost any preparation, while the use of YFP on biopsic
material is limited by the necessity to transfect cells with high
efficiency. However, when a stable YFP-transfected cell line is
obtained, it can be used to measure the functional expression of
CFTR without the preliminary steps of dye loading, and without
the decay of signal with time due to leakage of dye. These
techniques, in particular using the quenching of a YFP mutant by
iodide, have been successfully applied to high throughput
screening techniques [63,64].
5. Concluding remarks
We have presented a list of methods to evaluate the
functional properties of CFTR as the chloride transport across
the CFTR channel. These methods provide different degrees of
precision of the measurement, from absolute values of ionic
flux, to semi-quantitative evaluation of activity, to a simple
qualitative assess of CFTR expression. On the other hand,
every technique is suited to a specific preparation. Therefore,
the choice of the method to be used will depend on three main
factors:
1- What is the preparation to be used? Methods to evaluate
CFTR function in biopsic samples of epithelia may not be
appropriate for isolated cells.
493O. Moran, O. Zegarra-Moran / Journal of Cystic Fibrosis 7 (2008) 483–4942- What is the objective of the measurement? The experimental
design to measure the molecular mechanism of CFTR, or a
detailed pharmacological analysis is different than the design
to assess qualitatively but rapidly the expression of CFTR or
a high throughput screening of a chemical library in drug
discovery programs. In general, there is an inverse relation
between the precision of the technique and the throughput of
measurements.
3- What is the experience of the operator? All methods require
special training to obtain reliable results and to interpret
them. Thus, time spent in training on a given technique will
avoid fake results or mis-interpreted data.
It is noteworthy that, when measuring ion fluxes mediated by
CFTR, chloride and other ions could also flow through other
channels, pumps and transporters, interfering with the evalua-
tion of CFTR activity. Therefore, it is necessary to design
adequate controls, using inhibitors of specific ion pathways or
by modifying the solutions composition in order to change the
ion gradients, and thereby dissecting carefully the CFTR
contribution to the ion flux.
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